BOSTON SCIENTIFIC CORP — Director's Dealing 2018

Feb 26, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2018-02-23

Reporting Person: Fitzgerald Joseph Michael (EVP & President, Rhythm Mgmt)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-02-23	Common Stock	M	4138.0000	$0.0000	Acquired	180780.0000	Direct
2018-02-23	Common Stock	F	1887.0000	$27.2000	Disposed	178893.0000	Direct
2018-02-24	Common Stock	M	4778.0000	$0.0000	Acquired	183671.0000	Direct
2018-02-24	Common Stock	F	2179.0000	$27.2000	Disposed	181492.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-02-23	Deferred Stock Units	$	M	4138.0000	Disposed	2020-02-23	Common Stock (4138.0000)	Direct
2018-02-24	Deferred Stock Units	$0.0000	M	4778.0000	Disposed	2019-02-24	Common Stock (4778.0000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	77323.0000	Indirect

Footnotes

F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F2: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.

F3: Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.

F4: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant.

F5: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.